|
CA2170020C
(en)
|
1992-12-29 |
2005-08-02 |
Dale J. Kempf |
Retroviral protease inhibiting compounds
|
|
IL110752A
(en)
|
1993-09-13 |
2000-07-26 |
Abbott Lab |
Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
|
|
US5559158A
(en)
|
1993-10-01 |
1996-09-24 |
Abbott Laboratories |
Pharmaceutical composition
|
|
IL111991A
(en)
|
1994-01-28 |
2000-07-26 |
Abbott Lab |
Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
|
|
US6037157A
(en)
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
|
US6054472A
(en)
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
HUP0004421A3
(en)
|
1996-04-23 |
2002-10-28 |
Vertex Pharmaceuticals Inc Cam |
Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme
|
|
EP0966465B1
(en)
|
1997-03-14 |
2003-07-09 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of impdh enzyme
|
|
US20040058982A1
(en)
|
1999-02-17 |
2004-03-25 |
Bioavailability System, Llc |
Pharmaceutical compositions
|
|
AP1498A
(en)
|
1999-03-19 |
2005-11-21 |
Vertex Pharma |
Inhibitors of impdh enzyme.
|
|
WO2002000851A2
(en)
|
2000-06-28 |
2002-01-03 |
National Research Council Of Canada |
Helicobacter dd-heptosyltransferase
|
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
|
SK286630B6
(sk)
|
2001-01-22 |
2009-02-05 |
Merck & Co., Inc. |
Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
|
|
US6881741B2
(en)
|
2001-06-11 |
2005-04-19 |
Virochem Pharma Inc. |
Compounds and methods for the treatment or prevention of Flavivirus infections
|
|
CA2369711A1
(en)
|
2002-01-30 |
2003-07-30 |
Boehringer Ingelheim (Canada) Ltd. |
Macrocyclic peptides active against the hepatitis c virus
|
|
US6642204B2
(en)
|
2002-02-01 |
2003-11-04 |
Boehringer Ingelheim International Gmbh |
Hepatitis C inhibitor tri-peptides
|
|
CA2369970A1
(en)
|
2002-02-01 |
2003-08-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor tri-peptides
|
|
US7091184B2
(en)
|
2002-02-01 |
2006-08-15 |
Boehringer Ingelheim International Gmbh |
Hepatitis C inhibitor tri-peptides
|
|
WO2004013300A2
(en)
|
2002-08-01 |
2004-02-12 |
Pharmasset Inc. |
Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections
|
|
CA2413705A1
(en)
|
2002-12-06 |
2004-06-06 |
Raul Altman |
Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions
|
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
US7098231B2
(en)
|
2003-01-22 |
2006-08-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
BRPI0407587A
(pt)
|
2003-02-18 |
2006-02-14 |
Pfizer |
inibidores do vìrus da hepatite c, composições e tratamentos que os utilizam
|
|
CA2516016C
(en)
|
2003-03-05 |
2012-05-29 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibiting compounds
|
|
US6908901B2
(en)
|
2003-03-05 |
2005-06-21 |
Boehringer Ingelheim International, Gmbh |
Hepatitis C inhibitor peptide analogs
|
|
CL2004001161A1
(es)
|
2003-05-21 |
2005-04-08 |
Boehringer Ingelheim Int |
Compuestos describe compuestos derivados de quinolina; composicion farmaceutica; y su uso para tratar una enfermedad causada por el virus de la hepatitis c.
|
|
WO2005018330A1
(en)
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
|
EP1670415A4
(en)
|
2003-09-12 |
2007-12-05 |
Vertex Pharma |
ANIMAL MODEL FOR STUDYING PROTEASES ACTIVITY AND HEPATIC DISORDERS
|
|
US6933760B2
(en)
|
2003-09-19 |
2005-08-23 |
Intel Corporation |
Reference voltage generator for hysteresis circuit
|
|
ES2361997T3
(es)
|
2003-09-22 |
2011-06-27 |
Boehringer Ingelheim International Gmbh |
Péptidos macrocíclicos activos contra el virus de la hepatitis c.
|
|
US7132504B2
(en)
|
2003-11-12 |
2006-11-07 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
ATE495185T1
(de)
|
2004-01-21 |
2011-01-15 |
Boehringer Ingelheim Int |
Makrocyclische peptide mit wirkung gegen das hepatitis-c-virus
|
|
CN102911161A
(zh)
|
2004-02-20 |
2013-02-06 |
贝林格尔.英格海姆国际有限公司 |
病毒聚合酶抑制剂
|
|
US20050187192A1
(en)
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
|
US20050288333A1
(en)
|
2004-06-08 |
2005-12-29 |
Kem William R |
Controlling angiogenesis with anabaseine analogs
|
|
TW201424733A
(zh)
*
|
2004-10-29 |
2014-07-01 |
Vertex Pharma |
劑量型式
|
|
EP1991229A2
(en)
|
2006-02-27 |
2008-11-19 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
|
EP1993994A2
(en)
|
2006-03-16 |
2008-11-26 |
Vertex Pharmceuticals Incorporated |
Deuterated hepatitis c protease inhibitors
|
|
WO2007109605A2
(en)
|
2006-03-20 |
2007-09-27 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
|
CA2645566A1
(en)
|
2006-03-20 |
2007-09-27 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
|
JP5290186B2
(ja)
*
|
2006-11-15 |
2013-09-18 |
ヴァイロケム ファーマ インコーポレイテッド |
フラビウイルス感染症の治療または予防用のチオフェン類似体
|
|
MX2009006806A
(es)
|
2006-12-22 |
2009-08-27 |
Vertex Pharma |
Secado por rocio fluidizado.
|
|
DK2114924T3
(da)
|
2007-02-27 |
2012-04-10 |
Vertex Pharma |
Co-krystaller og farmaceutiske sammensætninger omfattende disse
|
|
JP2010528013A
(ja)
|
2007-05-21 |
2010-08-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｖｘ−９５０を含む用量形態およびそれらの投与レジメン
|
|
CA2691444C
(en)
*
|
2007-06-29 |
2016-06-14 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
|
WO2010002998A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Gilead Sciences, Inc. |
2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
|